National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN ORP Recent News
NCCN ORP Scientific Publications
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN ORP for Industry
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Duke Cancer Institute
Durham, North Carolina
888.275.3853 (888.ASK.DUKE)
www.cancer.duke.edu

Learn more about clinical trials at this NCCN Member Institution.

Profile

In 1972, the Duke Comprehensive Cancer Center, now known as the Duke Cancer Institute, was established and designated by NCI as one of the original comprehensive centers. The Duke Cancer Institute (DCI) is charged to serve as the center of all Duke activities in cancer. It is a single entity—the first of its kind at Duke - that integrates and aligns patient care and research with the goals of improving patient outcomes, decreasing the burden of cancer and accelerating scientific progress.

The Duke Cancer Institute, located in Durham, North Carolina, has outstanding multidisciplinary programs for all types of cancer. In these programs, physicians, scientists, nurses, and other health care professionals representing various clinical specialties provide comprehensive, individualized treatment for patients. Annually, more than 50,000 individuals with cancer are seen at the Duke Cancer Institute. Drawn by the Cancer Institute's national and international reputation, more than 20 percent of these patients come from outside of North Carolina.

U.S. News & World Report has consistently ranked Duke as one of the top cancer centers in the country. Particular strengths of the Duke Cancer Institute include The Preston Robert Tisch Brain Tumor Center at Duke, breast and ovarian oncology, adult and pediatric stem cell transplantation (including bone marrow and cord blood transplantation), thoracic oncology (esophageal and lung cancer), and experimental therapeutics including hyperthermia and cancer vaccines. The Duke Cancer Institute also has an outstanding, Cancer for Cancer Survivorship, Cancer Patient Support Program and Oncology Recreation Therapy Program.

Duke Cancer Institute reaches out to the larger community through programs such as the Duke Oncology Network, a consortium of affiliated practices throughout the southeast.

The Duke Cancer Institute offers a comprehensive range of medical services for children, adolescents, and young adults. Coordinated teams of physicians, nurses, nurse practitioners, physician assistants, psychologists, social workers, and others care for each patient in modern facilities, offering the latest advances in clinical care. Patients also can participate in both national and Duke-led clinical research studies testing new treatments.

The Hereditary Cancer Clinic at the Duke Cancer Institute, a member of the National Cancer Institute's Cancer Genetics Network, offers cancer risk assessment and education to cancer patients and people with a family history of cancer or other cancer risk factors. Duke's board-certified genetic counselor teams with medical oncologists to inform interested patients about their cancer risk, early detection, risk-reduction, and genetic testing. Through the Hereditary Cancer Clinic, individuals may be able to participate in research projects aimed at understanding and identifying the inherited genes that are important in cancer.